Menu Close

Novel blood metabolite biomarkers linked to Alzheimer’s disease

Alzheimer’s disease (AD) is the most common form of dementia and affects memory and thinking in the elderly. With a projected global increase in the number of affected individuals, reaching an estimated 152.8 million by 2050, health care systems are grappling with a substantial burden. There is an urgency to improve the understanding of its origin and find effective solutions for this growing public health issue.